These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181 [TBL] [Abstract][Full Text] [Related]
5. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Mocellin S; Pasquali S; Nitti D Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Meijerink MR; Puijk RS; van Tilborg AAJM; Henningsen KH; Fernandez LG; Neyt M; Heymans J; Frankema JS; de Jong KP; Richel DJ; Prevoo W; Vlayen J Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1189-1204. PubMed ID: 29666906 [TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation. Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609 [TBL] [Abstract][Full Text] [Related]
8. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207 [TBL] [Abstract][Full Text] [Related]
9. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Riemsma RP; Bala MM; Wolff R; Kleijnen J Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145 [TBL] [Abstract][Full Text] [Related]
10. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis. Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643 [TBL] [Abstract][Full Text] [Related]
11. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Riemsma RP; Bala MM; Wolff R; Kleijnen J Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373 [TBL] [Abstract][Full Text] [Related]
12. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125 [TBL] [Abstract][Full Text] [Related]
13. The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma. Liu B; Zhang Y; Chen H; Li W; Tsochatzis E Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013345. PubMed ID: 34981511 [TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Al-asfoor A; Fedorowicz Z Cochrane Database Syst Rev; 2007 Jul; (3):CD006039. PubMed ID: 17636822 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency in the Management of Colorectal Liver Metastases: A 10-Year Experience at a Single Center. Aissou S; Cartier V; Hamy A; Plumereau F; Aube C; Lermite E Surg Technol Int; 2016 Oct; 29():99-105. PubMed ID: 27780345 [TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. Wong SL; Mangu PB; Choti MA; Crocenzi TS; Dodd GD; Dorfman GS; Eng C; Fong Y; Giusti AF; Lu D; Marsland TA; Michelson R; Poston GJ; Schrag D; Seidenfeld J; Benson AB J Clin Oncol; 2010 Jan; 28(3):493-508. PubMed ID: 19841322 [TBL] [Abstract][Full Text] [Related]
18. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Scaife CL; Curley SA; Izzo F; Marra P; Delrio P; Daniele B; Cremona F; Gershenwald JE; Chase JL; Lozano RD; Patt YZ; Fornage BD; Vauthey JN; Woodall ML; Gonzalez KB; Ellis LM Ann Surg Oncol; 2003 May; 10(4):348-54. PubMed ID: 12734081 [TBL] [Abstract][Full Text] [Related]
19. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Al-Asfoor A; Fedorowicz Z; Lodge M Cochrane Database Syst Rev; 2008 Apr; (2):CD006039. PubMed ID: 18425932 [TBL] [Abstract][Full Text] [Related]
20. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cirocchi R; Trastulli S; Abraha I; Vettoretto N; Boselli C; Montedori A; Parisi A; Noya G; Platell C Cochrane Database Syst Rev; 2012 Aug; (8):CD008997. PubMed ID: 22895981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]